<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="retraction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38125103</article-id><article-id pub-id-type="pmc">PMC10732865</article-id><article-id pub-id-type="doi">10.1155/2023/9787205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Retraction</subject></subj-group></article-categories><title-group><article-title>Retracted: Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>and Alternative Medicine</surname><given-names>Evidence-Based Complementary</given-names></name><email>ecam@hindawi.com</email></contrib></contrib-group><aff id="I1">
<addr-line/>
</aff><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>12</month><year>2023</year></pub-date><volume>2023</volume><elocation-id>9787205</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2023 Evidence-Based Complementary and Alternative Medicine.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article related-article-type="retracted-article" ext-link-type="doi" id="RA1" xlink:href="10.1155/2022/8060026" vol="2022" elocation-id="8060026"/></article-meta></front><body><p>This article has been retracted by Hindawi, as publisher, following an investigation undertaken by the publisher [<xref rid="B1" ref-type="bibr">1</xref>]. This investigation has uncovered evidence of systematic manipulation of the publication and peer-review process. We cannot, therefore, vouch for the reliability or integrity of this article.</p><p>Please note that this notice is intended solely to alert readers that the peer-review process of this article has been compromised.</p><p>Wiley and Hindawi regret that the usual quality checks did not identify these issues before publication and have since put additional measures in place to safeguard research integrity.</p><p>We wish to credit our Research Integrity and Research Publishing teams and anonymous and named external researchers and research integrity experts for contributing to this investigation.</p><p>The corresponding author, as the representative of all authors, has been given the opportunity to register their agreement or disagreement to this retraction. We have kept a record of any response received.</p></body><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>J.</given-names></name>
<name><surname>Ni</surname><given-names>X.</given-names></name>
<name><surname>Ji</surname><given-names>J.</given-names></name>
<name><surname>Wei</surname><given-names>G.</given-names></name>
<name><surname>Shi</surname><given-names>L.</given-names></name>
<name><surname>Xu</surname><given-names>C.</given-names></name>
</person-group><article-title>Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines</article-title><source>
<italic>Evidence-Based Complementary and Alternative Medicine</italic>
</source><year>2022</year><volume>2022</volume><fpage>6</fpage><pub-id pub-id-type="publisher-id">8060026</pub-id><pub-id pub-id-type="doi">10.1155/2022/8060026</pub-id><pub-id pub-id-type="pmid">35529932</pub-id>
</element-citation></ref></ref-list></back></article>
